Vol. 65 No. 5 (2019), ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

Vol. 65 No. 5 (2019)

INNOVATIVE APPROACHES TO THE DIAGNOSIS OF SKIN MELANOMA: DEVELOPMENT VECTORS (INTERMEDIATE RESULTS)

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2019-65-5-744-748

Published 01.05.2019

Yelena Antonova⁺⁻
Irina Baldueva⁺⁻
Aleksandr Solovev⁺⁻
A. Baranov⁺⁻
A. Khambikova⁺⁻
Tatyana Nekhaeva⁺⁻
L. Wayn⁺⁻
A. Zamir⁺⁻
I. Sinai⁺⁻

Yelena Antonova

Ulyanovsk State Pedagogical University

Irina Baldueva

N.N. Petrov National Medical Research Center of Oncology

Aleksandr Solovev

Ulyanovsk State Pedagogical University

A. Baranov

Ulyanovsk State Pedagogical University

A. Khambikova

Ulyanovsk State Pedagogical University

Tatyana Nekhaeva

N.N. Petrov National Medical Research Center of Oncology

L. Wayn

Emerald Medical Applications Ltd

A. Zamir

Emerald Medical Applications Ltd

I. Sinai

Emerald Medical Applications Ltd

##article.numberofdownloads## 54

##article.numberofviews## 130

PDF (Русский)

Keywords

SNP-ПОЛИМОРФИЗМЫ
MELANOMA
HEREDITARY
SCREENING
SNP
FREQUENCIES

How to Cite

Antonova, Y., Baldueva, I., Solovev, A., Baranov, A., Khambikova, A., Nekhaeva, T., Wayn, L., Zamir, A., & Sinai, I. (2019). INNOVATIVE APPROACHES TO THE DIAGNOSIS OF SKIN MELANOMA: DEVELOPMENT VECTORS (INTERMEDIATE RESULTS). Voprosy Onkologii, 65(5), 744–748. https://doi.org/10.37469/0507-3758-2019-65-5-744-748

Abstract

This article represents intermediate results of the research of the international project on the direction of complex diagnostics of skin melanoma. A preliminary screening of patients was carried out, which included the analysis of molecular markers of genomic DNA causing the development of susceptibility to the development of melanoma. In this paper, 7 gene polymorphisms of CDKN2A (cyclin-dependent kinase inhibitor 2A), MC1R (melanocortin 1 receptor) and MITF (microphthalmia transcription factor) are considered. In total, 122 patients were studied.

https://doi.org/10.37469/0507-3758-2019-65-5-744-748

##article.numberofdownloads## 54

##article.numberofviews## 130

PDF (Русский)

References

Мазуренко Н.Н. Генетические особенности и маркеры меланомы кожи // Успехи молекулярной онкологии. - 2014. - № 2. - С. 36-43.

Kumar S., Stecher G., Tamura K. MEGA7: Molecular Evolutionary Genetics Analysis version 7.0 for bigger datasets // Molecular Biology and Evolution. - 2016. - Vol. 33. - P. 1870-1874.

Новик А.В. Меланома кожи: новые подходы // Практическая онкология. - 2011. - Т. 2. - № 1. - С. 36-42.

Bohm M., Jagirdar K., Sturm R.A. et al. Lack of protection from development of multiple melanomas by an injected melanocortin analogue in a combined high-risk MC1R/ CDKN2A genotype patient // Journal of European Academy of Dermatology and Venereology. - 2016. - Vol. 30, Is. 10. - P. 65-67.

Botezatu I.V., Nechaeva I.O., Stroganova A.M. et al. Optimization of melting analysis with Taqman probes for de tection of KRAS, NRAS and BRAF mutations // Analytical Biochemistry. - 2015. - Vol. 491. - P. 75-83.

Davies M.A., Samuels Y Analysis of the genome to personalize therapy for melanoma // Oncogene. - 2010. - Vol. 29 (41). - P. 5545-5555.

Delaunay J., Martin L., de Paillerets B.D. et al. Improvement of Genetic Testing for Cutaneous Melanoma in Countries With Lowto Moderate Incidence. The Rule of 2 vs the Rule of 3 // JAMA Dermatology. - 2017. - Vol. 153 (11). - P. 1122-1129.

Fargnoli M.C., Gandini S., Peris K. et al. MC1R variants increase melanoma risk in families with CDKN2A mutations: A meta-analysis // European Journal of Cancer. - 2010. - Vol. 46. - P. 1413-1420.

Harlanda M., Goldsteinb A.M., Kukalizcha K. et al. A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL) // European Journal of Cancer. - 2008. - Vol. 44 (9). - P. 1269-1274.

Hayward N.K., Wilmott J.S., Waddell N. et al. Whole-ge-nome landscapes of major melanoma subtypes // Nature. - 2017. - Vol. 545 (7653). - P. 175-180.

Helgadottir H., Tuominen R., Olsson H. et al. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status // Journal of American Academy of Dermatology. - 2017. - Vol. 77 (5). - P. 893-901.

Helgadottir H., Hoiom V., Tuominen R. et al. Germline CD-KN2A Mutation Status and Survival in Familial Melanoma Cases // Journal of the National Cancer Institute. - 2016. - Vol. 108 (11). - DOI: 10.1093/jnci/djw135

Leachman S.A., Olivia M. Lucero O.M. et al. Identification, genetic testing, and management of hereditary melanoma // Cancer Metastasis Rev. - 2017. - Vol. 36. - P. 77-90.

Levin T, Mæhle L. Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway // Familial Cancer. - 2017. - Vol. 16. - P. 257-265.

Lynch H.T., Shaw T.G. Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity // Familial Cancer. - 2016. - Vol. 15 (3). - P. 487-491.

Mangas C., Potrony M., Mainetti C. et al. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF // British Journal of Dermatology. - 2016. - Vol. 175 (5). - P. 1030-1037.

Melamed R.D., Aydin I.T., Rajan G.S. et al. Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma // The Journal of Investigative Dermatology. - 2017. - Vol. 137 (4). - P. 905-909.

Soura E., Eliades P.J., Shannon K. et al. Hereditary melanoma: Update on syndromes and management. Emerging melanoma cancer complexes and genetic counseling // Journal of American Academy of Dermatology. - 2016. - Vol. 74. - P. 411-420.

Taylor N.J., Mitra N., Goldstein A.M. et al. Germline variation at CDKN2A and associations with nevus phenotypes among members of melanoma families // The Journal of Investigative Dermatology. - 2017. - Vol. 137 (12). - P. 2606-2612.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Svetlana Kulyova , Ksenia Borokshinova , Irina Baldueva , Tatiana Nekhaeva , Anna Artemyeva , Natalia Efremova , Natalya Emelyanova , Alexei Novik , Sergey Novikov, Mikhail Girshovich , Evgeny Senchurov , Elvira Gumbatova , Rina Khabarova , Elena Mikhailova , Yulia Semenova , Gaziz Sakhautdinov , Experience with multitargeted antitumor vaccine in a child with diffuse midline glioma, H3 K27M-mutant , Voprosy onkologii : Vol. 69 No. 3 (2023)
Anton Zozulia, Irina Baldueva, Anna Artemeva, Sergei Novikov, Anastasiia Muravtseva, Dmitrii Girdiuk, Natalia Emelianova, Elena Tiuriaeva, Elena Fedosova, Filipp Antipov, Andrei Arsenev, Mikhail Girshovich, Sergei Kanaev, Aleksei Beliaev, Changes of immune status in patients with different PD-L1 expression after stereotactic body radiation therapy of oligometastasis , Voprosy onkologii : Vol. 67 No. 6 (2021)
Anton Zozulya, Sergey Novikov, Irina Baldueva, D. Girdyuk, Natalya Yemelyanova, Yelena Tyuryaeva, E. Fedosova, F. Antipov, A. Navoloka, Sergey Kanaev, Aleksey Belyaev, CHANGES IN THE IMMUNE STATUS OF PATIENTS WITH METASTATIC SOLID TUMORS DURING STEREOTACTIC RADIATION THERAPY , Voprosy onkologii : Vol. 66 No. 3 (2020)
Anna Danilova, Tatiana Nekhaeva, Natalia Efremova, Aleksei Novik, Anton Zozulia, Georgii Gafton, Irina Baldueva, Assessment of the effectiveness of the use of tumoroids for personalized drug therapies for solid tumors , Voprosy onkologii : Vol. 67 No. 6 (2021)
Tatyana Semiglazova, Natalya Buevich, Yekaterina Anokhina, Yevgeniya Kharchenko, Mikhail Osipov, Veronika Klimenko, Margarita Motalkina, Yuriy Komarov, Gulfiya Teletaeva, Dilorom Latipova, Sergey Alekseev, Larisa Filatova, Aleksey Novik, Anna Semenova, Irina Baldueva, Aleksandr Stukov, Svetlana Protsenko, Z. Kotova, HOW APPROACHES TO DRUG THERAPY FOR MALIGNANT TUMORS HAVE CHANGED (TO THE FIRST DOMESTIC ANTITUMOR DRUG IS DEDICATED) , Voprosy onkologii : Vol. 63 No. 2 (2017)
A. Oganesian, Svetlana Protsenko, Irina Baldueva, Anna Semenova, Yekaterina Anokhina, Aleksey Novik, EVALUATION OF THE EFFECTIVENESS OF MODERN IMMUNOTHERAPY , Voprosy onkologii : Vol. 66 No. 3 (2020)
Irina Baldueva, Tatyana Nekhaeva, Aleksei Belyaev, Mesenchimal stem cells in treatment of cancer patients with COVID-19 pneumonia , Voprosy onkologii : Vol. 67 No. 1 (2021)
Anton Zozulia, Irina Baldueva, Sergei Novikov , Dmitrii Girdiuk, Natalia Emelianova, Elena Tyuryaeva, Elena Fedosova, Filipp Antipov, Andrei Arsenev, Irina Korobova , Mikhail Girshovich, Sergey Kanaev, Aleksey Belyaev, Changes in the immune status of patients with metastatic solid tumors during stereotactic radiation therapy: dependence on dose and amount of irradiated metastasis , Voprosy onkologii : Vol. 67 No. 3 (2021)
Tatyana Nekhaeva, A. Chernov, Yana Toropova, Mikhail Galagudza, Irina Baldueva, VARIETY OF TUMOR MODELS FOR TESTING ANTITUM TREATMENT ACTIVITY OF SUBSTANCES IN MICE , Voprosy onkologii : Vol. 66 No. 4 (2020)
Alexandr Chernov, Irina Baldueva, Tatyana Nekhaeva, Elvira Galimova, Diana Alaverdian, Olga Shamova, The molecular mechanisms of multidrug resistance of human glioblastomas , Voprosy onkologii : Vol. 67 No. 1 (2021)

1 2 > >>